SC
CLB icon

Shellback Capital’s Core Laboratories CLB Stock Holding History

Shellback Capital’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-71,376
Closed -$8.14M – 80
2015
Q2 		$8.14M Buy
+71,376
New +$8.65M 0.57% 67

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Shellback Capital's CLB Position: Q3 2015 in Review

Shellback Capital sold out of Core Laboratories (CLB) in Q3 2015, closing a stake of 71,376 shares — an estimated $8.14M sold.

Shellback Capital first reported a position in CLB in Q2 2015 and held it in 1 quarter. The position peaked at $8.14M in Q2 2015. 352 funds tracked by Wall St. Rank hold CLB as of Q3 2015.

  • Shellback Capital reported no remaining Core Laboratories position as of Q3 2015 after selling out during the quarter.
  • Shellback Capital sold 71,376 Core Laboratories shares in Q3 2015, an estimated $8.14M.
  • Shellback Capital first reported a position in Core Laboratories in Q2 2015 and held it in 1 quarter.
  • Shellback Capital's Core Laboratories position peaked at $8.14M in Q2 2015.
  • 352 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2015.

Based on Shellback Capital's 13F filing for Q3 2015, filed 16 Nov 2015.